Cyclazodone is a centrally acting stimulant drug developed by American Cyanamid Company in the 1960s.

[2] The patents concluded that cyclazodone possessed properties efficacious in reducing fatigue and as a potential anorectic.

[3] Structural congeners of pemoline have been described as "excitants with unique properties distinguishing them from the sympathomimetic amines" whilst displaying less stimulatory activity and toxicity compared to amphetamine.

[5] Cyclazodone has not been evaluated by the United States Food and Drug Administration for use in humans as a nootropic, anorectic, or stimulant and thus safety information is lacking.

This drug article relating to the nervous system is a stub.